Landscape Capital Management L.L.C. Has $3.17 Million Stake in Docusign Inc. $DOCU

Key Points

• Landscape Capital Management L.L.C. increased its stake in Docusign Inc. by 52.8% in the first quarter, acquiring an additional 13,460 shares, bringing its total holdings to 38,962 shares valued at approximately $3.17 million.
• Several hedge funds have also significantly boosted their positions in Docusign, with Hemington Wealth Management increasing its stake by 318.1% and Golden State Wealth Management by 519.4% in the same period.
• Morgan Stanley, UBS Group, and Bank of America all downgraded their target prices for Docusign, with the consensus rating currently at "Hold" and an average price target of $89.77.

Landscape Capital Management L.L.C. increased its stake in shares of Docusign Inc. (NASDAQ:DOCU - Free Report) by 52.8% in the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 38,962 shares of the company's stock after purchasing an additional 13,460 shares during the period. Landscape Capital Management L.L.C.'s holdings in Docusign were worth $3,172,000 as of its most recent SEC filing.

A number of other institutional investors have also made changes to their positions in the stock. Dimensional Fund Advisors LP grew its stake in Docusign by 23.6% in the fourth quarter. Dimensional Fund Advisors LP now owns 822,314 shares of the company's stock valued at $73,975,000 after acquiring an additional 156,841 shares during the period. MML Investors Services LLC grew its stake in Docusign by 38.9% in the fourth quarter. MML Investors Services LLC now owns 16,711 shares of the company's stock valued at $1,503,000 after acquiring an additional 4,677 shares during the period. Integrated Wealth Concepts LLC grew its stake in Docusign by 57.2% in the fourth quarter. Integrated Wealth Concepts LLC now owns 7,805 shares of the company's stock valued at $702,000 after acquiring an additional 2,841 shares during the period. The Manufacturers Life Insurance Company grew its stake in Docusign by 222.9% in the fourth quarter. The Manufacturers Life Insurance Company now owns 172,753 shares of the company's stock valued at $15,537,000 after acquiring an additional 119,245 shares during the period. Finally, Northern Trust Corp grew its stake in Docusign by 77.2% in the fourth quarter. Northern Trust Corp now owns 1,984,378 shares of the company's stock valued at $178,475,000 after acquiring an additional 864,408 shares during the period. 77.64% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Allan C. Thygesen sold 40,000 shares of the firm's stock in a transaction on Tuesday, July 1st. The stock was sold at an average price of $77.51, for a total transaction of $3,100,400.00. Following the sale, the chief executive officer owned 143,983 shares of the company's stock, valued at $11,160,122.33. This trade represents a 21.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, insider Robert Chatwani sold 22,875 shares of the firm's stock in a transaction on Wednesday, June 18th. The shares were sold at an average price of $74.79, for a total value of $1,710,821.25. Following the sale, the insider directly owned 72,126 shares in the company, valued at approximately $5,394,303.54. This trade represents a 24.08% decrease in their position. The disclosure for this sale can be found here. In the last 90 days, insiders sold 78,552 shares of company stock worth $5,983,631. 1.66% of the stock is owned by company insiders.

Docusign Trading Down 3.2%

Shares of DOCU traded down $2.45 during mid-day trading on Tuesday, reaching $74.21. The company's stock had a trading volume of 1,592,373 shares, compared to its average volume of 2,561,618. Docusign Inc. has a 1-year low of $54.31 and a 1-year high of $107.86. The stock has a market cap of $15.00 billion, a P/E ratio of 14.02, a PEG ratio of 28.61 and a beta of 1.02. The business has a 50-day simple moving average of $75.46 and a two-hundred day simple moving average of $79.59.

Docusign (NASDAQ:DOCU - Get Free Report) last announced its earnings results on Thursday, June 5th. The company reported $0.90 earnings per share for the quarter, topping analysts' consensus estimates of $0.81 by $0.09. The company had revenue of $763.65 million for the quarter, compared to analyst estimates of $748.79 million. Docusign had a return on equity of 14.27% and a net margin of 36.50%.The firm's quarterly revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the company earned $0.82 earnings per share. Docusign has set its FY 2026 guidance at EPS. Q2 2026 guidance at EPS. Research analysts anticipate that Docusign Inc. will post 1.17 EPS for the current year.

Docusign declared that its board has authorized a stock buyback program on Thursday, June 5th that allows the company to repurchase $1.00 billion in shares. This repurchase authorization allows the company to purchase up to 6.6% of its shares through open market purchases. Shares repurchase programs are often an indication that the company's management believes its stock is undervalued.

Wall Street Analysts Forecast Growth

A number of research analysts have issued reports on DOCU shares. Wall Street Zen cut Docusign from a "buy" rating to a "hold" rating in a research note on Saturday, August 2nd. Needham & Company LLC reaffirmed a "hold" rating on shares of Docusign in a research report on Friday, June 6th. Wedbush reduced their price objective on Docusign from $100.00 to $85.00 and set a "neutral" rating for the company in a research report on Thursday, June 12th. Wells Fargo & Company raised Docusign from an "underweight" rating to an "equal weight" rating and upped their price objective for the stock from $67.00 to $80.00 in a research report on Friday, June 13th. Finally, Morgan Stanley reduced their price objective on Docusign from $92.00 to $86.00 and set an "equal weight" rating for the company in a research report on Friday, June 6th. Four research analysts have rated the stock with a Buy rating and twelve have given a Hold rating to the company. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $89.77.

Docusign Company Profile

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.